Crossing Borders: Factors Affecting Differences in Cost-Effectiveness of Smoking Cessation Interventions between European Countries

Efficacy of Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

2006 • 1,630 citations

Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

2006 • 1,343 citations

Antidepressants for smoking cessation

2020 • 1,245 citations

Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies

2003 • 1,122 citations

Antidepressants for smoking cessation

2003 • 703 citations

Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study

2003 • 603 citations

Gesundheitsberichterstattung des Bundes

2010 • 520 citations

Health Technology Assessment (HTA)

2007 • 466 citations

Defining post-stroke recovery: implications for design and interpretation of drug trials

2000 • 393 citations

Smoking vs Other Risk Factors as the Cause of Smoking-Attributable Deaths

2000 • 315 citations

Recent trends in physician diagnosed COPD in women and men in the UK

2000 • 306 citations

Disability weights for diseases in the Netherlands

1997 • 274 citations

Unit Costs of Health and Social Care 2006

2006 • 249 citations

The Impact of Aging and Smoking on the Future Burden of Chronic Obstructive Pulmonary Disease

2001 • 221 citations

Recent Developments in Decision-Analytic Modelling for Economic Evaluation

2006 • 215 citations

A Meta-Analysis of Quality-of-Life Estimates for Stroke

2003 • 211 citations

Variations in Stroke Incidence and Survival in 3 Areas of Europe

2000 • 160 citations

The Economic Burden of Stroke in the United Kingdom

2003 • 152 citations

Cost-Effectiveness of Face-to-Face Smoking Cessation Interventions: A Dynamic Modeling Study

2005 • 141 citations

Development of an Economic Model to Assess the Cost Effectiveness of Treatment Interventions for Chronic Obstructive Pulmonary Disease

2005 • 137 citations

Coronary event and case fatality rates in an English population: results of the Oxford myocardial infarction incidence study

1998 • 137 citations

Echocardiographic Identification of Cardiovascular Sources of Emboli To Guide Clinical Management of Stroke: A Cost-Effectiveness Analysis

1997 • 131 citations

Cost of stroke in Sweden: An incidence estimate

2004 • 128 citations

The Uninsured Patient

2006 • 127 citations

Quality of Life and Utility in Patients with Non-Small Cell Lung Cancer

2001 • 117 citations

Cost-Effectiveness of Preference-Based Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation

1998 • 113 citations

Cost of Stroke

1993 • 106 citations

Cost-Utility Analysis of Varenicline versus Existing Smoking Cessation Strategies using the BENESCO Simulation Model

2008 • 96 citations

Psychometric and Utility-Based Measures of Health Status of Asthmatic Patients with Different Disease Control Level

2004 • 87 citations

Unit Costs of Health and Social Care 2005

2006 • 83 citations

Disability weights for comorbidity and their influence on Health-adjusted Life Expectancy

2006 • 83 citations

Development of the health and economic consequences of smoking interactive model

2001 • 75 citations

Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparison

2006 • 73 citations

Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands

2007 • 72 citations

The SCOPE Study: Health-Care Consumption Related to Patients with Chronic Obstructive Pulmonary Disease in France

2004 • 66 citations

Deutsche Empfehlungen zur gesundheitsökonomischen Evaluation

2000 • 64 citations

Future costs of stroke in the Netherlands: The impact of stroke services

2006 • 60 citations

Krankheitskosten von COPD in Deutschland

2004 • 55 citations

Long term outcome and cost-effectiveness of stenting versus balloon angioplasty for acute myocardial infarction

2001 • 53 citations

Krebs in Deutschland 2003-2004 Häufigkeiten und Trends

2008 • 46 citations

Varenicline as compared to bupropion in smoking-cessation therapy—Cost–utility results for Sweden 2003

2008 • 44 citations

Cost-effectiveness of pravastatin in secondary prevention of coronary heart disease: comparison between Belgium and the United States of a projected risk model

1998 • 41 citations

Cost-Utility Analysis of Varenicline, an Oral Smoking-Cessation Drug, in Japan

2009 • 37 citations

Cost Effectiveness of Treating Low HDL-Cholesterol in the Primary Prevention of Coronary Heart Disease

2005 • 37 citations

Varenicline in the management of smoking cessation: a single technology appraisal

2009 • 32 citations

Health Economics of Chronic Obstructive Pulmonary Disease

2006 • 32 citations

Telefonischer Gesundheitssurvey des RKI zu chronischen Krankheiten und ihren Bedingungen – Deskriptiver Ergebnisbericht

2005 • 29 citations

The Economic Burden

2010 • 28 citations

Impact économique de la BPCO en France : étude SCOPE

2005 • 23 citations

[Projections of future resource use and the costs of asthma and COPD in the Netherlands].

2006 • 19 citations

Cost-effectiveness of interventions to reduce tobacco smoking in the Netherlands. An application of the RIVM Chronic Disease Model

2006 • 18 citations

Cost-effectiveness of interventions to reduce tobacco smoking in the Netherlands

2006 • 10 citations

[Chronic bronchitis. Development, prevention].

1988 • 4 citations

PRS13 THE COST-EFFECTIVENESS OF VARENICLINE IN SMOKING CESSATION IN DENMARK

2008 • 3 citations

[Respiratory pathology in occupational medicine: evaluation of 3 methods of data collection and research on risk factors].

1984 • 2 citations

La bronchite chronique

2009 • 2 citations

PRS20 A LONG TERM COST-EFFECTIVENESS ANALYSIS MODEL FOR SMOKING CESSATION IN KOREA

2008 • 2 citations

PRS11 LONG TERM COST-EFFECTIVENESS AND COST-UTILITY ANALYSIS FOR SMOKING CESSATION IN CZECH REPUBLIC

2008 • 1 citations

PRS11 MANAGEMENT OF COPD IN BELGIUM: A REAL LIFE COST OF ILLNESS STUDY

2005 • 1 citations

[Towards a decrease of myocardial infarction in the Bas-Rhin region? Results of the 6 first years of the Strasbourg MONIC Register].

1994 • 1 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...